Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00671918 · ClinicalTrials.gov registry record · Phase 3
Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
A Phase 3 study, sponsored by Navidea Biopharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 186
- Enrollment target
NCT00671918 is a Phase 3 study that has completed, run by Navidea Biopharmaceuticals. The registered enrollment target is 186 participants.
The verdict
NCT00671918, a Phase 3 study, has completed, sponsored by Navidea Biopharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 186 participants
- Enrollment target
Study Summary
Data from this pivotal clinical trial will be used to support a marketing application (i.e., NDA) for Navidea's Lymphoseek for use in intraoperative localization of lymph tissue (nodes) in the lymphatic pathway draining the primary site of a tumor.
Interventions
- DRUG Lymphoseek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00671918
The ClinicalTrials.gov registry entry for NCT00671918 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Navidea Biopharmaceuticals, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lymphoseek is the first listed.
NCT00671918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00671918 about?
NCT00671918 is a clinical study titled "Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma". Data from this pivotal clinical trial will be used to support a marketing application (i.e., NDA) for Navidea's Lymphoseek for use in intraoperative localization of lymph tissue (nodes) in the lymphatic pathway draining the primary site of a tumor.
What is the current status of trial NCT00671918?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 186 participants. The study started on 2008-04. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00671918?
The interventions under investigation include: Lymphoseek (DRUG).
Who is sponsoring clinical trial NCT00671918?
This trial is sponsored by Navidea Biopharmaceuticals, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.